Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $9.31 in the prior trading day, Ardelyx Inc (NASDAQ: ARDX) closed at $8.48, down -8.92%. In other words, the price has decreased by -$8.92 from its previous closing price. On the day, 5.29 million shares were traded. ARDX stock price reached its highest trading level at $9.1954 during the session, while it also had its lowest trading level at $8.395.
Ratios:
Our goal is to gain a better understanding of ARDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.53. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.67.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on April 05, 2024, initiated with a Outperform rating and assigned the stock a target price of $14.
On December 18, 2023, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $12.
On September 07, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on September 07, 2023, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 03 ’24 when GRAMMER ELIZABETH A sold 45,000 shares for $9.00 per share. The transaction valued at 405,000 led to the insider holds 267,993 shares of the business.
Williams Laura A sold 39,949 shares of ARDX for $333,574 on May 03 ’24. The Chief Medical Officer now owns 370,189 shares after completing the transaction at $8.35 per share. On Apr 29 ’24, another insider, RAAB MICHAEL, who serves as the President & CEO of the company, sold 30,000 shares for $6.40 each. As a result, the insider received 192,057 and left with 1,310,933 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1984124800 and an Enterprise Value of 2102550912. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.47 while its Price-to-Book (P/B) ratio in mrq is 13.15. Its current Enterprise Value per Revenue stands at 13.214 whereas that against EBITDA is -34.782.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.82, which has changed by 1.1353211 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $10.13, while it has fallen to a 52-week low of $3.16. The 50-Day Moving Average of the stock is 9.96%, while the 200-Day Moving Average is calculated to be 42.13%.
Shares Statistics:
The stock has traded on average 6.07M shares per day over the past 3-months and 8021420 shares per day over the last 10 days, according to various share statistics. A total of 232.45M shares are outstanding, with a floating share count of 224.94M. Insiders hold about 3.86% of the company’s shares, while institutions hold 58.74% stake in the company. Shares short for ARDX as of 1713139200 were 33925866 with a Short Ratio of 5.59, compared to 1710460800 on 36305566. Therefore, it implies a Short% of Shares Outstanding of 33925866 and a Short% of Float of 16.510001.
Earnings Estimates
The market rating for Ardelyx Inc (ARDX) is a result of the insights provided by 10.0 analysts actively involved in the assessment.On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.16, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.09, with high estimates of $0.0 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.1 and -$0.59 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is $0.12, with 10.0 analysts recommending between $0.45 and -$0.22.
Revenue Estimates
10 analysts predict $53.9M in revenue for the current quarter. It ranges from a high estimate of $60.4M to a low estimate of $41.63M. As of the current estimate, Ardelyx Inc’s year-ago sales were $15.27MFor the next quarter, 10 analysts are estimating revenue of $64.41M. There is a high estimate of $75.25M for the next quarter, whereas the lowest estimate is $47.41M.
A total of 10 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $273.08M, while the lowest revenue estimate was $184.41M, resulting in an average revenue estimate of $239.54M. In the same quarter a year ago, actual revenue was $124.46MBased on 10 analysts’ estimates, the company’s revenue will be $396.16M in the next fiscal year. The high estimate is $468.69M and the low estimate is $323.74M.
